Jan‐Patrik Wiksten

752 total citations
10 papers, 646 citations indexed

About

Jan‐Patrik Wiksten is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jan‐Patrik Wiksten has authored 10 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jan‐Patrik Wiksten's work include Glycosylation and Glycoproteins Research (3 papers), RNA modifications and cancer (3 papers) and Cancer-related Molecular Pathways (3 papers). Jan‐Patrik Wiksten is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), RNA modifications and cancer (3 papers) and Cancer-related Molecular Pathways (3 papers). Jan‐Patrik Wiksten collaborates with scholars based in Finland. Jan‐Patrik Wiksten's co-authors include Stig Nordling, Arto Kokkola, Caj Haglund, Johan Lundin, Johanna Mrena, Mikael Lundin, Ari Ristimäki, Caj Haglund, Kristina von Boguslawski and Alexandra Thiel and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Jan‐Patrik Wiksten

10 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan‐Patrik Wiksten Finland 10 390 213 154 127 101 10 646
Y. Doki Japan 8 616 1.6× 239 1.1× 94 0.6× 86 0.7× 110 1.1× 13 940
Romina Dossi Italy 10 453 1.2× 201 0.9× 158 1.0× 103 0.8× 81 0.8× 11 708
Rinat Keren United States 5 532 1.4× 327 1.5× 160 1.0× 141 1.1× 63 0.6× 5 763
Gary Oxford United States 10 646 1.7× 280 1.3× 164 1.1× 161 1.3× 108 1.1× 13 878
Carole Voland France 10 308 0.8× 202 0.9× 125 0.8× 54 0.4× 65 0.6× 11 564
Masafumi Kumano Japan 13 379 1.0× 237 1.1× 137 0.9× 97 0.8× 208 2.1× 33 692
Marisa Mariani United States 15 476 1.2× 249 1.2× 235 1.5× 148 1.2× 73 0.7× 24 758
Gvantsa Kharaishvili Czechia 18 404 1.0× 347 1.6× 221 1.4× 107 0.8× 153 1.5× 26 776
Shereen Keleg Germany 16 581 1.5× 463 2.2× 184 1.2× 76 0.6× 68 0.7× 20 917
Elke Hiendlmeyer Germany 7 445 1.1× 318 1.5× 136 0.9× 70 0.6× 60 0.6× 7 672

Countries citing papers authored by Jan‐Patrik Wiksten

Since Specialization
Citations

This map shows the geographic impact of Jan‐Patrik Wiksten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Patrik Wiksten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Patrik Wiksten more than expected).

Fields of papers citing papers by Jan‐Patrik Wiksten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Patrik Wiksten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Patrik Wiksten. The network helps show where Jan‐Patrik Wiksten may publish in the future.

Co-authorship network of co-authors of Jan‐Patrik Wiksten

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Patrik Wiksten. A scholar is included among the top collaborators of Jan‐Patrik Wiksten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Patrik Wiksten. Jan‐Patrik Wiksten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Koskensalo, Selja, Johanna Mrena, Jan‐Patrik Wiksten, et al.. (2010). MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumor Biology. 31(3). 149–155. 53 indexed citations
2.
Mrena, Johanna, Jan‐Patrik Wiksten, Arto Kokkola, et al.. (2009). COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. Tumor Biology. 31(1). 1–7. 50 indexed citations
3.
Khanna, Anchit, Camilla Böckelman, Annabrita Hemmes, et al.. (2009). MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer. JNCI Journal of the National Cancer Institute. 101(11). 793–805. 156 indexed citations
4.
Wiksten, Jan‐Patrik, Johan Lundin, Stig Nordling, Arto Kokkola, & Caj Haglund. (2008). Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.. PubMed. 28(4C). 2279–87. 26 indexed citations
5.
Mrena, Johanna, Jan‐Patrik Wiksten, Arto Kokkola, et al.. (2006). Prognostic significance of cyclin A in gastric cancer. International Journal of Cancer. 119(8). 1897–1901. 45 indexed citations
6.
Lundin, Johan, Stig Nordling, Jorma Isola, Jan‐Patrik Wiksten, & Caj Haglund. (2005). Epithelial Syndecan-1 Expression Is Associated with Stage and Grade in Colorectal Cancer. Oncology. 68(4-6). 306–313. 45 indexed citations
7.
Mrena, Johanna, Jan‐Patrik Wiksten, Alexandra Thiel, et al.. (2005). Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Cancer and Its Expression Is Regulated by the Messenger RNA Stability Factor HuR. Clinical Cancer Research. 11(20). 7362–7368. 129 indexed citations
8.
Wiksten, Jan‐Patrik, Johan Lundin, Stig Nordling, et al.. (2003). Tenascin-C Expression Correlates with Prognosis in Gastric Cancer. Oncology. 64(3). 245–250. 25 indexed citations
9.
Wiksten, Jan‐Patrik, Johan Lundin, Stig Nordling, et al.. (2002). The Prognostic Value of p27 in Gastric Cancer. Oncology. 63(2). 180–184. 30 indexed citations
10.
Wiksten, Jan‐Patrik, Johan Lundin, Stig Nordling, et al.. (2001). Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. International Journal of Cancer. 95(1). 1–6. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Doki Breakdown of academic impact, for papers by Romina Dossi Breakdown of academic impact, for papers by Rinat Keren Breakdown of academic impact, for papers by Gary Oxford Breakdown of academic impact, for papers by Carole Voland Breakdown of academic impact, for papers by Masafumi Kumano Breakdown of academic impact, for papers by Marisa Mariani Breakdown of academic impact, for papers by Gvantsa Kharaishvili Breakdown of academic impact, for papers by Shereen Keleg Breakdown of academic impact, for papers by Elke Hiendlmeyer
Rankless by CCL
2026